Senior insider sale
EVP Research at REGENERON PHARMACEUTICALS, INC. — senior position signals high conviction
$3.20M
4.15K shares
What this filing means
MURPHY ANDREW J plans to sell 4.15K shares of REGENERON PHARMACEUTICALS, INC. valued at approximately $3.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/14/2026ACC: 0001969223-26-001073
Officer· EVP Research
Since Dec 2019
4.15K
Shares to sell
$3.20M
Approx. market value
4.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Net Exercise
10/13/2026
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/13/2026 | Exercise of Stock Options Net Exercise | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
4.15K
Market value
$3.20M
10/14/2026
Total
Units
4.15K
Value
$3.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/14/2026 | 4.15K | $3.20M | Nasdaq | Planned |
| Total | 4.15K | $3.20M | ||